Figure 3 shows the absolute numbers of the CD8+ subpopulations CD28+CD57-, CD28+CD57+, CD28-CD57- and CD28-CD57+ among the participants, including the cancer stages, over the six months period. This evidence concerns the gene CD8A and cancer.